Anna Mas

1.1k total citations
9 papers, 531 citations indexed

About

Anna Mas is a scholar working on Molecular Biology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Anna Mas has authored 9 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Clinical Biochemistry. Recurrent topics in Anna Mas's work include Mitochondrial Function and Pathology (3 papers), Metabolism and Genetic Disorders (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Anna Mas is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Metabolism and Genetic Disorders (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Anna Mas collaborates with scholars based in Spain, Netherlands and Italy. Anna Mas's co-authors include Marta Torrens, Jordi Camı́, Magı́ Farré, Vı́ctor Moreno, Rafael Artuch, Jaume Campistol, María Antònia Vilaseca, Belén Pérez‐Dueñas, Nilo Lambruschini and Miguel Carneiro de Moura and has published in prestigious journals such as The American Journal of Gastroenterology, Drug and Alcohol Dependence and Clinical Biochemistry.

In The Last Decade

Anna Mas

8 papers receiving 501 citations

Peers

Anna Mas

EPIDE

MB

HEPAT

CB

PHEOH

Valentina Colonna Italy

C. C. P. Aires Portugal

Octavio Campollo Mexico

J. A. Duley United Kingdom

Akihiko Kinugasa Japan

Lucy Goodman New Zealand

Gail Sekas United States

J. V. Leonard United Kingdom

Cecilia Dao United States

Kerstin B. Menander United States

Valentina Colonna Italy

Anna Mas

94 ×0.4

EPIDE

137 ×0.8

MB

29 ×0.2

HEPAT

96 ×0.8

CB

14 ×0.1

PHEOH

Citations per year, relative to Anna Mas Anna Mas (= 1×) peers Valentina Colonna

Countries citing papers authored by Anna Mas

Since Specialization

Citations

This map shows the geographic impact of Anna Mas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mas more than expected).

Fields of papers citing papers by Anna Mas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mas. The network helps show where Anna Mas may publish in the future.

Co-authorship network of co-authors of Anna Mas

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mas. A scholar is included among the top collaborators of Anna Mas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mas. Anna Mas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Pinilla, Lucía, Esther Gràcia‐Lavedan, Anna Mas, et al.. (2021). Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study. Journal of Thoracic Disease. 13(3). 1485–1494. 15 indexed citations

2.

Campistol, Jaume, Carmen Fons, Judith Armstrong, et al.. (2011). Glycine and l-Arginine Treatment Causes Hyperhomocysteinemia in Cerebral Creatine Transporter Deficiency Patients. JIMD Reports. 4. 13–16. 4 indexed citations

3.

Pineda, Mercè, Javier Arpa, Raquel Montero, et al.. (2008). Idebenone treatment in paediatric and adult patients with Friedreich ataxia: Long-term follow-up. European Journal of Paediatric Neurology. 12(6). 470–475. 79 indexed citations

4.

Lambruschini, Nilo, Belén Pérez‐Dueñas, María Antònia Vilaseca, et al.. (2005). Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy. Molecular Genetics and Metabolism. 86. 54–60. 81 indexed citations

5.

Pérez‐Dueñas, Belén, María Antònia Vilaseca, Anna Mas, et al.. (2004). Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Clinical Biochemistry. 37(12). 1083–1090. 41 indexed citations

6.

Farré, Magı́, Anna Mas, Marta Torrens, Vı́ctor Moreno, & Jordi Camı́. (2002). Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug and Alcohol Dependence. 65(3). 283–290. 158 indexed citations

7.

Farré, Magı́, Pere N. Roset, Marta Más, & Anna Mas. (1998). Biodisponibilidad de medicamentos. Medicina Clínica. 110(14). 3 indexed citations

8.

Fattovich, Giovanna, G. Giustina, J.M. Sánchez‐Tapias, et al.. (1998). Delayed Clearance of Serum HBsAg in Compensated Cirrhosis B: Relation to Interferon Alpha Therapy and Disease Prognosis. The American Journal of Gastroenterology. 93(6). 896–900. 147 indexed citations

9.

Fattovich, Giovanna, G. Giustina, J.M. Sánchez-Tapias, et al.. (1998). Delayed clearance of serum HBsAg in compensated cirrhosis B. European Journal of Gastroenterology & Hepatology. 10(10). 901–901. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact